The optimal neoadjuvant treatment of locally advanced esophageal cancer
Berend J. van der Wilk(Erasmus MC Cancer Institute), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Ben M. Eyck(Erasmus MC Cancer Institute), Joost J. Nuyttens(Erasmus MC Cancer Institute), Ate van der Gaast(Erasmus MC)
Cited by 29
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788